Ankara Training and Research Hospital
Ankara, Turkey (Türkiye)
NCT Number: NCT06632340
Investigators aim to investigate the effect of the size of the base of the tumor in contact with the bladder mucosa on recurrence and progression in non-muscle invasive bladder tumors.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Ankara, Turkey (Türkiye)
Between March 2021 and September 2023, 130 patients who applied to our clinic with complaints of hematuria, dysuria, and suprapubic pain, and who were diagnosed with bladder tumor by imaging methods and underwent TUR-MT were included in the study. The groups were compared in terms of age, gender, smoking, ASA, comorbidities, BMI and the number of tumors, size, stage as intraoperative and postoperative data. Patients with tumor base size <2 cm were classified as Group
1, while with tumor base size ≥2 cm were classified as Group 2. Kaplan Meier survival analysis without recurrence and without progression were performed after comparing the groups in terms of recurrence and progression.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transurethral resection of bladder tumor
Time frame: 2 year
Time frame: 2 year
Ankara Training and Research Hospital
Other
Effect of Tumor Base Size on Recurrence and Progression in Non-muscle Invasise Bladder Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02675829
Bladder Cancer, Female Urogenital Diseases
Basking Ridge, New Jersey, United States
View Trial DetailsNCT05864144
Adenocarcinoma, Adnexal Diseases
Los Angeles, California, United States
View Trial DetailsNCT02657486
Bladder Cancer, Female Urogenital Diseases
New York, United States
View Trial DetailsNCT07798479
Bladder Cancer, Carcinoma
View Trial Details